Interim results of a phase II study of docetaxel (Taxotere™) in unresectable non-small cell lung cancer (NSCLC) on 204 chemotherapy naive or pretreated patients
Year: 1997
Type: article
Source: European Journal of Cancer
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1991927485
